Cti Biopharma reported $99.4M in Current Assets for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Baxter International BAX:US USD 8.01B 201M
Cti Biopharma CTIC:US USD 99.4M 2.46M
Cytori Therapeutics CYTX:US USD 21.82M 938K
Geron GERN:US USD 180.25M 41.82M
Mirati Therapeutics MRTX:US USD 1.11B 116.82M
Northwest Biotherapeutics NWBO:US USD 11.76M 4.59M
Novartis NOVN:VX USD 36.91B 44M
Novartis NVS:US USD 36.91B 44M
Seattle Genetics SGEN:US USD 2.8B 42.91M
Teva Pharmaceutical Industries TEVA:US USD 12.05B 598M
YTE INCY:US USD 4.09B 271.74M